See the DrugPatentWatch profile for repatha
What does “tier 1” usually mean for Repatha?
“Tier 1” depends on the specific insurance plan. Most formularies use tiers to rank drugs by expected cost and coverage rules:
- Tier 1 is typically the lowest out-of-pocket cost (often $0–$25 for preferred generics or certain preferred brands).
- A brand like Repatha (evolocumab) is more commonly placed in a higher tier, frequently tier 3 or tier 4, but it can be tier 1 on some plans if it’s a preferred brand.
Because placement varies by insurer and geography, there isn’t a single universal answer.
What to check to confirm if Repatha is Tier 1 on your plan
To find out whether Repatha is tier 1 for you, check your plan’s:
- Formulary (preferred drugs list)
- “Drug tier” or “cost share” section for “Repatha” / “evolocumab”
- Any coverage requirements listed next to it (for example prior authorization or step therapy)
Does manufacturer assistance affect the “tier” label?
Patient assistance programs or copay cards usually reduce your out-of-pocket cost, but they typically do not change the formulary tier itself. Your plan can still list Repatha as a higher tier even if copay support makes your cost lower.
How Repatha is often covered compared with other PCSK9 inhibitors
Repatha and similar cholesterol-lowering injections in the PCSK9 inhibitor class (like Praluent/alirocumab) are sometimes positioned differently across formularies. So even if one is Tier 1 on a given plan, the other may not be.
If you tell me your plan name, I can help you interpret it
If you share the insurer and plan type (for example, “Aetna Medicaid,” “Blue Cross PPO,” “Medicare Advantage plan name,” or the tier/cost shown on your formulary), I can help you interpret whether Repatha is truly Tier 1 for that coverage level.
---
Sources
No sources were provided with your question, and tier placement is plan-specific, so I can’t verify “Tier 1” without your formulary/plan details. If you want, paste the formulary line for Repatha and I’ll confirm what it means.